Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-03-28
2006-03-28
Saeed, Kamal A. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S300000
Reexamination Certificate
active
07019151
ABSTRACT:
Compounds having the structure I:are useful for inducing cell death (apoptosis) and in immunosuppression. In structure I, R1is H or R, R being selected from lower alkyl, alkenyl, alkynyl, and allenyl, or, R1together with R2=O (oxo); R2=OH, or, R1and R2together=O (oxo); CR3R5and CR4R6are selected from CH2, CHOH and CROH; at least one of R1, R5and R6is R; and at least one of CR3R5and CR4R6is CH2.
REFERENCES:
patent: 5430054 (1995-07-01), Qian et al.
patent: 5663335 (1997-09-01), Qi et al.
patent: 6004999 (1999-12-01), Jung et al.
patent: 6150539 (2000-11-01), Musser
patent: 6620843 (2003-09-01), Fidler et al.
Copy of International Search Report in PCT/US2003/040104, published on Jul. 15, 2004 as WO 2004/058246 A1.
Dai Dongcheng
Musser John H.
Gorthey LeeAnn
Parker Michael P.
Perkins Coie LLP
Pharmagenesis, Inc.
Saeed Kamal A.
LandOfFree
Triptolide derivatives as immunomodulators and anticancer... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triptolide derivatives as immunomodulators and anticancer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triptolide derivatives as immunomodulators and anticancer... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3585380